Testing a nutrition program to lower blood sugar levels
Official title: Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
Run by Viome · NCT06185192 · Data updated 2026-11-12
This study is testing if a personalized nutrition program can help people with diabetes lower their blood sugar levels over 90 days.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Viome Industry-sponsored |
| Locations | 1 site (Bothell, Washington) |
| Status | Recruiting |
| Started | December 13, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | January 29, 2025 |
| Trial ID | NCT06185192 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with HbA1c levels between 6.5-8.9% who are willing to follow the program's dietary recommendations.
✕Probably not a fit
Patients currently using insulin or specific medications to manage diabetes, or those on restrictive diets, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, placebo-controlled trial evaluates the effectiveness of Viome's Precision Nutrition Program (VPNP) in reducing HbA1c levels in participants with diabetes. Eligible individuals will be recruited directly and will undergo a series of assessments, including blood draws and sample collections, at the beginning and end of a 90-day intervention period. Participants will receive personalized dietary recommendations and supplements based on their individual health data. The study aims to determine if these tailored nutrition strategies can significantly lower HbA1c levels compared to a placebo.
Why it matters
Potential benefit: If successful, this program could provide a personalized approach to managing diabetes and improving blood sugar control.
How similar studies have gone: While personalized nutrition approaches are gaining traction, this specific intervention is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed and dated informed consent form and medical release prior to any trial-specific procedures are performed * Females and males aged 18 years or older * Able to speak and read English * HbA1c between 6.5-8.9% (inclusive), tested within the past 30 days * Willing and able to visit a Quest Diagnostic Patient Service Center (PSC) * Willing and able to follow the trial instructions and Viome's Precision Nutrition Program * Willing and able to use a smartphone and Viome app. Exclusion Criteria: * Antibiotic use within one month of the GI test * Gestation within previous 6 month * Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.) * Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.) * On a specific diet, such as ketogenic, for the purpose of reducing HbA1c and/or weight within the previous month * Taking diet pills * Allergy to an ingredient in the MH capsule or stick pack * Currently on an investigational product * Significant surgery or medical procedure planned * Diet or lifestyle change during the trial period, besides those appropriate for trial arm Has followed Viome nutritional recommendations (foods and/or supplements)
Where it's running
-
Viome Life Sciences
Bothell, Washington, United States Recruiting
Study contacts
- Principal investigator: Momchilo Vuyisich — Viome
- Study coordinator: Mory Mehrtash
- Email: studies@viome.com
- Phone: (425) 300-6933
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.